JPMorgan Chase & Co. Trims Stock Position in PTC Therapeutics, Inc. $PTCT
JPMorgan Chase & Co. cut its holdings in PTC Therapeutics, Inc. (NASDAQ:PTCT - Free Report) by 18.4% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 490,934 shares of the biopharmaceutical company's stock after s...